October 2, 2017 Clinical Trials in Psoriatic Disease Webinar

October 2, 2017

Please join Andrew Blauvelt, M.D., MBA, as he discusses clinical trials in psoriatic diseases. 

Monday, October 2, 2017 4:00 p.m. Pacific / 6:00 p.m. Central / 7:00 p.m. Eastern

Register Here, through GoToWebinar to attend this live 1.0 hour CME-accredited educational webinar.

Unable to attend the webinar during the specified time? Watch it as an enduring material! All webinars will be posted for a period of two years following its live session.

This program is supported by unrestricted educational grants from Eli Lilly & Company, Celgene Corporation, Valeant Pharmaceuticals North America, LLC and Dermira Inc..

Accreditation Statement

The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit

The National Psoriasis Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Target Audience

Dermatologists, Rheumatologists, Allied Health, Primary Care

Learning Objectives

  1. Identify resources and best practices for recruiting and communicating with participants
  1. Identify and respond to common questions and concerns patients may have about participating in a clinical trial to ensure informed consent is a shared decision making process
  1. Utilize best practices in preparing for and implementing a psoriatic disease clinical trial in their practice
  1. Identify resources and information necessary to keep abreast of relevant clinical trials and confidently screen and recommend potential patients for participation.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Accreditation

    This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint providership of Oregon Health & Science University (OHSU) and the National Psoriasis Foundation. OHSU is accredited by the ACCME to provide CME for physicians.

    Credit

    OHSU School of Medicine, Division of CME, designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 CE
Course opens: 
07/19/2017
Course expires: 
10/02/2017
Event starts: 
10/02/2017 - 4:00pm
Event ends: 
10/02/2017 - 5:00pm
Cost:
$0.00
Rating: 
0
Andrew Blauvelt, MD, MBA
President and Investigator
Oregon Medical Research Center
Portland, Oregon

Accreditation Period

Course opens: 
07/19/2017
Course expires: 
10/02/2017

Price

Cost:
$0.00
Please login to take this course.